Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).

Jackson TL, Desai R, Wafa HA, Lee CN, Wang Y, Peacock JL, Peto T, Chakravarthy U, Zhu X, Dakin H, Wordsworth S, Clinch P, Ramazzotto L, Neffendorf JE, O'Sullivan JM, Reeves BC, STAR study group

Year

2026

Journal

BMJ (Clinical research ed.)